Tessera Therapeutics
Ben Hoogheem serves as the Senior Director and Head of Talent Management at Tessera Therapeutics, where responsibilities include overseeing talent acquisition for a pioneering company in genome engineering technology, known for its mission to cure diseases by writing in the code of life. Prior experience includes leadership roles in talent acquisition at Flagship Pioneering, Laronde, Generate Biomedicines, Cellarity, and Ring Therapeutics, as well as a client partnership at Stratacuity. Ben's earlier career includes significant scientific contributions at Novartis Institutes for BioMedical Research, Gilead Sciences, and a solid educational background with a Bachelor of Science in Molecular and Cellular Biology from the University of Illinois Urbana-Champaign.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.